Therapeutic Drug Monitoring

Therapeutical drug monitoring is defined as the clinical laboratory measurement of a chemical parameter that will directly influence drug prescribing procedures after appropriate medical interpretation. TDM refers to maintaining blood drug or plasma concentrations within a targeted therapeutic range or window for the individualization of drug dosage. Drug Monitoring begins after the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and patient characteristics like age, organ function, weight and concomitant drug therapy.

The global therapeutic drug monitoring market was valued USD 1.77 billion in 2015 and it will be expected to reach over USD 3.37 billion by 2024 and shows significant growth in CAGR over the last few years.

  •  Therapeutic range
  • Biomonitoring
  • Blood glucose monitoring

Related Conference of Therapeutic Drug Monitoring

March 13-14, 2025

2nd International Conference on Drug Discovery and Development

Prague, Czech Republic
April 07-08, 2025

15th World Congress on Chemistry

Vancouver, Canada
May 14-15, 2025

17th International Conference on Clinical Chemistry

Toronto, Canada
June 26-27, 2025

14th World Congress on Chromatography

Paris, France
August 18-19, 2025

14th World Congress on Biopolymers and Biomaterials

Valencia, Spain
September 22-23, 2025

21st European Organic Chemistry Congress

Dubai, UAE
October 27-28, 2025

15th International Chemistry Congress

London, UK
November 06-07, 2025

6th World Expo on Biopolymers and Bioplastics

Dubai, UAE
December 08-09, 2025

5th International Conference on Analytical Chemistry

Rome, Italy

Therapeutic Drug Monitoring Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in